Orexin-A vs Desmopressin
Head-to-head comparison of Orexin-A (Hypocretin-1 (Orexin-A)) and Desmopressin (1-Deamino-8-D-arginine vasopressin) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Orexin-A | Desmopressin |
|---|---|---|
| Category | Cognitive Enhancement | Cognitive Enhancement |
| Full Name | Hypocretin-1 (Orexin-A) | 1-Deamino-8-D-arginine vasopressin |
| Molecular Weight | 3562 Da | 1069.22 Da |
| Half-Life | Minutes to <1 hour | 1.5-3 hours |
| Amino Acids | 33 | 9 |
| Typical Dose | Research-only; no validated human dose | 10-40 mcg intranasal |
| Route | Intracerebroventricular/Intranasal | Intranasal/Oral |
| Purity | ≥98% | ≥98% |
| Studies Count | 42 | 35 |
| Research Status | Pre-clinical | Clinical |
Orexin-A Benefits
- ✓wakefulness
- ✓attention
- ✓memory consolidation
- ✓fatigue resistance
Desmopressin Benefits
- ✓memory consolidation
- ✓reduced pressor burden
- ✓recall support
- ✓short-term learning
Orexin-A Dosing
Research-only i.c.v. microgram/nanomolar studies|intranasal experimental use|no established human protocol
Desmopressin Dosing
intranasal research dosing|10-40 mcg or IU-equivalent studies|single-dose protocols
Orexin-A Side Effects
- ⚠insomnia
- ⚠headache
- ⚠blood pressure changes
Desmopressin Side Effects
- ⚠hyponatremia
- ⚠headache
- ⚠nasal irritation
Research Overview
Orexin-A
Preclinical studies link orexin signaling to arousal, learning, and memory consolidation, making orexin-A a candidate for cognition-related research. It is not an approved cognitive enhancer and remains an experimental peptide.
Desmopressin
The literature is mixed, but desmopressin has shown memory-related effects in selected populations and experimental paradigms. Its cognitive effects are usually discussed as a vasopressin-pathway probe rather than a primary nootropic.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.